Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report on the current, pipeline and emerging drugs for the treatment of peripheral neuropathy and neuropathic pain. "Peripheral Neuropathy and Neuropathic Pain, 2007" estimates that these two conditions affect 170-270 million individuals globally. Both peripheral neuropathy and neuropathic pain are causally linked to various diseases - but their links to diabetes, cancer and HIV alone are likely to increase prevalence by more than 10% in the next five years.

Authors of the report say that peripheral neuropathy and neuropathic pain are both exceedingly difficult to treat as they do not have a cure. The drugs used presently for the treatment of the latter condition are often antidepressants or anticonvulsants which were developed to treat other primary indications. So patients often do not find available therapies helpful.

The study lists and assesses today's drug armoury and looks ahead to the drug development pipeline taking into account all candidate drugs, starting from those at pre-clinical stages, right down to those ready for the initial launch. In this section, it profiles 80 drugs being developed to treat peripheral neuropathy and neuropathic pain as primary indications and 60 second indication drugs.

The report outlines the capabilities and failings of current therapy. It assesses the strategies being developed to combat both PN and NP and points to the drug candidates that are most likely to hit the market. The study also profiles companies with a stake in this particular market, details market sizes and estimates growth over the next five years.

"Peripheral Neuropathy and Neuropathic Pain, 2007" is available in pdf format from Piribo. For more information, go to: http://www.piribo.com/publications/diseases_conditions/pain/peripheral_neuropathy_and_neuropathic_pain_2007.html

Piribo product ID: BPR003

About Piribo
Piribo (http:www.piribo.com) is a UK-based independent online store supplying business information on the pharmaceutical and biotechnology industries. The website now carries over 6,000 English language titles including, market reports, studies and books and is the UK's largest online biopharma information store. Subscribers receive a free monthly newsletter and email alerts on new titles in their areas of interest. The company was established in 2004.